Table 2.
Comorbidities prior to the event
| Women | Men | SMD | |
|---|---|---|---|
| n | 14 270 | 29 023 | |
| Anxiety disorders | 2075 (14.5) | 2763 (9.5) | 0.155 |
| Aortic valve disorder | 793 (5.6) | 1793 (6.2) | 0.026 |
| Atrial fibrillation | 2475 (17.3) | 6575 (22.7) | 0.133 |
| Arthrosis | 2615 (18.3) | 3994 (13.8) | 0.125 |
| Chronic ischaemic heart disease | 2126 (14.9) | 7061 (24.3) | 0.239 |
| Chronic obstructive pulmonary disease | 2110 (14.8) | 2991 (10.3) | 0.136 |
| Diabetes mellitus type 1 | 928 (6.5) | 2129 (7.3) | 0.033 |
| Diabetes mellitus type 2 | 2510 (17.6) | 5651 (19.5) | 0.048 |
| Delusional/mood disorders | 2465 (17.3) | 3161 (10.9) | 0.184 |
| Dementia | 1451 (10.2) | 1819 (6.3) | 0.142 |
| Heart failure | 3029 (21.2) | 7079 (24.4) | 0.075 |
| Hypertension | 6616 (46.4) | 12 572 (43.4) | 0.061 |
| Kidney disease | 1214 (8.5) | 3029 (10.4) | 0.066 |
| Late effects of cerebrovascular disease | 948 (6.7) | 2042 (7.0) | 0.016 |
| Myocardial infarction | 1526 (10.7) | 4372 (15.1) | 0.131 |
| Stroke | 1229 (8.6) | 2537 (8.7) | 0.005 |
| Substance abuse disorder | 1944 (13.6) | 4472 (15.4) | 0.051 |
Values are n (%).SMD, standardized mean difference.